Bruce Lavin | Vice President and Head of Medical Neurology
UCB

Bruce Lavin, Vice President and Head of Medical Neurology, UCB

Dr. Bruce Lavin is Vice President and Head – Medical Affairs, Neurology Patient Value Unit and Head of External Engagement and Policy. He is also an actively practicing physician in Internal Medicine, Infectious Diseases, and Critical Care.
Dr. Lavin has more than 30 years of Clinical and Academic experience in Internal Medicine, Infectious Diseases, and Trauma, including over 19 years of Pharmaceutical Industry experience. He has lead Medical Affairs and Clinical Development programs and multiple therapeutic divisions for major pharmaceutical companies in the areas of Neurology, Immunology, Virology and Anti-Infectives.  Previously, Dr. Lavin was the Vice President and Therapeutic Head for Bristol-Myers Squibb where he led the U.S. clinical activities for HIV, HBV, HCV, as well as in Rheumatology and Transplant. Prior to Bristol-Myers Squibb, he held senior medical executive roles for both Novartis and Sanofi-Aventis in the areas of Infectious Disease, Immunology, Transplantation, Virology and the Central Nervous System. Dr. Lavin previously served as Head of Clinical Medicine in the Northern California VA system. He has also served 36 years as a Navy Medical Officer, directing Academic Clinical Medicine, US Marine Corps operational support, and Military Medical Research, retiring as Captain in the US Navy.
Dr. Lavin holds a Bachelor’s degree from the University of California Irvine and a Master’s Degree of Public Health from the University of California, Los Angeles. He received his Medical Degree from the F. Herbert School of Medicine in Maryland. He is Board Certified in Internal Medicine and Infectious Diseases and has certifications in Aerospace Medicine, Outcomes Research, and Health Law.

Appearances:



Day Two World Pharma Pricing & Market Access EU Congress @ 14:10

Using RWE for infectious diseases

  • Identifying the unmet needs and opportunities
  • Generating and using evidence to develop solutions
  • Delivering value and positive outcomes for patients

back to speakers